Rheumatoid Arthritis News

Primary nonadherence — in which patients fail to start new prescriptions — for methotrexate and biologics/tofacitinib is common in those with rheumatoid arthritis, according to findings published in Arthritis Research and Therapy.

Sandoz received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use for its proposed adalimumab biosimilar for the treatment of all indications of its reference product, including rheumatoid arthritis, plaque psoriasis, Crohn's disease and ulcerative colitis, according to a manufacturer release.

The FDA has approved a once-daily dose of baricitinib 2 mg for the treatment of adults with moderate-to-severe rheumatoid arthritis who have had an inadequate response to one or more TNF inhibitors, according to a press release.

Despite the elevated risk for cardiovascular disease associated with rheumatoid arthritis, and regardless of their blood pressure levels, most patients with rheumatoid arthritis did not receive any documented communication regarding blood pressure, according to findings published in the Journal of Clinical Rheumatology.

Physicians need to have full knowledge of their patients’ needs, preferences and priorities, as well as their pain characteristics and history, to enact personalized management plans, which should include patient education and considerations for multidisciplinary intervention, according to recommendations published by a EULAR task force.

The risk for autoimmune disease among teenage girls does not increase after they receive the quadrivalent HPV vaccine, according to findings published in the Canadian Medical Association Journal.

Patients with rheumatoid arthritis who achieved low disease activity following combination treatment with tocilizumab and methotrexate may safely discontinue methotrexate without significant worsening of disease activity, according to recent findings.

DESTIN, Fla. — Although the incidence of rheumatologic adverse effects associated with immune checkpoint inhibitors is expected to grow with their increased use, these effects remain poorly studied in random clinical trials, according to findings presented at the 2018 Congress of Clinical Rheumatology.

DESTIN, Fla. — Rheumatoid arthritis is not an independent risk factor for cardiovascular mortality in end stage renal disease, according to findings presented that the 2018 North American Young Rheumatology Investigator Forum.

DESTIN, Fla. — The etanercept biosimilar, etanercept-szzs, demonstrated an equivalent clinical efficacy and safety profile to etanercept among patients with moderate-to-severe rheumatoid arthritis who failed to respond to disease-modifying anti-rheumatic drugs, according to findings presented at the 2018 Congress of Clinical Rheumatology.